Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity studyKelvin Kai‐Wang To, Kwok‐Yung Yuen, Cyril Chik‐Yan Yip et al.|Clinical Microbiology and Infection|2018Cited by 229
Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 vaccination: A self-controlled case series and nested case-control studyEric Yuk Fai Wan, Ian Chi Kei Wong, Kathy Leung et al.|The Lancet Regional Health - Western Pacific|2022Cited by 66
Viral burden rebound in hospitalised patients with COVID-19 receiving oral antivirals in Hong Kong: a population-wide retrospective cohort studyCarlos King Ho Wong, GM Leung, Kristy T. K. Lau et al.|The Lancet Infectious Diseases|2023Cited by 58
Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: A self-controlled case series studyCeline Sze Ling Chui, Ian Chi Kei Wong, Min Fan et al.|EClinicalMedicine|2022Cited by 55
Effectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Hospitalized Patients With COVID-19Eric Yuk Fai Wan, Esther W. Chan, Vincent Ka Chun Yan et al.|Annals of Internal Medicine|2023Cited by 54